Patents expiring in 2035

US 9056129

Precision-guided nanoparticle systems for drug delivery

Northwestern University · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056068

Vaccine and methods of use against Strongyloide stercoralis infection

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9055765

Dietary compositions and related methods of use

Northwestern University · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056087

Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives

REGENERX BIOPHARMACEUTICALS, INC. · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056100

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056847

Activity based probes (ABPs) interacting with glycosidases

ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056924

Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571

The Regents of the University of California · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056046

Standardized extract and its use in the manufacture of a medicament

Botanic Century (Beijing) Co. Ltd. · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056891

Synthetic peptide inhibitors of Wnt pathway

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056127

Hydrogel composition based on co-polymer carrying multiple pendant sulphonic groups for use as a wound dressing

FIRST WATER LIMITED · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056154

High-yield activation of polymer surfaces for covalent attachment of molecules

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056907

Human domain antibodies against components of the human insulin-like growth factor (IGF) system

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9057069

Compositions and methods for inhibiting expression of Eg5 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056054

Abuse resistant oral dosage forms

Elite Laboratories, Inc. · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056102

VEGF-activated trail ligands

The Regents of the University of California · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9057104

Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype

VANDA PHARMACEUTICALS INC. · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056130

Humanized Fc gamma R mice

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2882753

VERFAHREN ZUR HERSTELLUNG VON PEMETREXED UND EINEM LYSINSALZ DAVON

BERLIN CHEMIE AG [DE] · Granted Wed Jun 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jun 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9060995

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9060941

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Takeda Pharmaceutical Company Limited · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061063

Biodegradable lipids for the delivery of active agents

Alnylam Pharmaceuticals, Inc. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061026

Oligomer-diarylpiperazine conjugates

Nektar Therapeutics · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061030

sGC stimulators

IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061055

Oncolytic adenovirus armed with therapeutic genes

The Board of Regents of the University of Texas System · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061048

Cyclic di-AMP induction of type I interferon

The Regents of the University of California · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061981

Diphenyl substituted cyclohexane derivatives, useful as modulators of the estrogen receptors beta

ACADIA Pharmaceuticals Inc. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061027

Enhanced delivery of drug compositions to treat life threatening infections

The Board of Regents of the University of Texas System · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061071

Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels

The Regents of the University of California · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062008

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062093

Peptide compositions and methods for treating patients

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062007

Cyclic amide BACE-1 inhibitors having a benzamide substituent

Pharmacopeia Drug Discovery, Inc. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062310

Compositions and methods for inhibiting expression of factor VII gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062052

Carboxamide compounds and methods for using the same

Rigel Pharmaceuticals, Inc. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062075

Tetrahydropyridine derivatives as FabI inhibitors

Aurigene Discovery Technologies Limited · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9061016

Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease

APREA AB · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062095

Mutant double cyclized receptor peptides inhibiting β1-adrenoceptor antibodies

Julius-Maximilians-Universitat Wurzburg · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9063125

Compositions comprising cells expressing cold- and menthol-sensitive receptor (CMR1) polypeptides

The Regents of the University of California · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9063153

Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062288

Therapeutic methods using adipose tissue-derived cell suspensions comprising adipocytes

Regeneus LTD · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062297

Yersinia pestis vaccine

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062068

Protein kinase C inhibitors and uses thereof

Rigel Pharmaceuticals, Inc. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062002

Substituted pyridine derivatives as FabI inhibitors

Aurigene Discovery Technologies Limited · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9062347

Endothelin single nucleotide polymorphisms and methods of predicting β-adrenergic receptor targeting agent efficacy

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9060971

Combination pharmaceutical agents as inhibitors of HCV replication

Enanta Pharmaceuticals, Inc. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2886116

Benzodioxol-Derivate zur Verwendung in der Behandlung von Aufmerksamkeitsdefizitstörung und/oder Hyperaktivität

BIOCODEX [FR] · Granted Wed Jun 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jun 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2934118

PROPIONATE DE CORTEXOLONE-17' DESTINE A ETRE UTILISE DANS LE TRAITEMENT DE LESIONS CUTANEES ET/OU DE TROUBLES DE LA PEAU ATROPHIQUE

CASSIOPEA S P A [IT] · Granted Thu Jun 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jun 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9066900

Interferon-β production modulating listeria strains and methods for using same

The Regents of the University of California · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9066855

Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

The Regents of the University of California · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)